Endobronchial Ultrasound Guided Interstitial Photodynamic Therapy in Treating Patients With Locally Advanced Lung Cancer
Status:
Recruiting
Trial end date:
2022-02-04
Target enrollment:
Participant gender:
Summary
This Phase I/Ila studies the side effects of endobronchial ultrasound guided interstitial
photodynamic therapy work in treating patients with lung cancer that has spread to nearby
tissues or lymph nodes. Photodynamic therapy consists of injecting a light sensitive drug
called a photosensitizer, such as porfimer sodium, into the vein, waiting for it to
accumulate in the tumor, and then activating it with a red laser light. Giving photodynamic
therapy with Porfimer sodium may reduce the tumor size in patients with lung cancer.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Roswell Park Cancer Institute
Collaborators:
National Cancer Institute (NCI) Pinnacle Biologics Inc.